Passage Bio, Inc. (PASG) Earning

NASDAQ Currency in USD Disclaimer

$0.65

south_east -$0 (0.51%)
Day's range
$0.64
Day's range
$0.66

Passage Bio, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$0.31 -$0.31 -$0.31
Q2 2024 1 -$0.23 -$0.23 -$0.23
Q3 2024 1 -$0.24 -$0.19 -$0.22
Q1 2025 1 -$0.25 -$0.25 -$0.25
Q2 2025 1 -$0.25 -$0.25 -$0.25
Q3 2025 1 -$0.22 -$0.22 -$0.22
Q4 2025 1 -$0.22 -$0.22 -$0.22

Passage Bio, Inc. Earnings Date And Information

Passage Bio, Inc. last posted its earnings results on Thursday, August 8th, 2024. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.31 by $0.05. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Passage Bio, Inc. has generated $-2 earnings per share over the last year ($-1.86 diluted earnings per share) and currently has a price-to-earnings ratio of -0.58. Passage Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based on prior year's report dates.

Passage Bio, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/13/2024 Q3 2024 -$0.31 $1.67 M $0
08/08/2024 Q2 2024 -$0.31 -$0.26 0.05 $0 $0
05/14/2024 Q1 2024 -$0.37 -$0.30 0.07 $0
03/04/2024 Q4 2023 -$0.41 -$0.31 0.1 $5.91 M
11/13/2023 Q3 2023 -$0.47 -$0.49 -0.02 $0
08/07/2023 Q2 2023 -$0.48 -$0.44 0.04 $0
05/11/2023 Q1 2023 -$0.49 -$0.60 -0.11 $0
03/06/2023 Q4 2022 -$0.48 -$0.47 0.01 $0
11/10/2022 Q3 2022 -$0.75 -$0.48 0.27 $0
08/04/2022 Q2 2022 -$0.78 -$0.72 0.06 $0
05/16/2022 Q1 2022 -$0.88 -$0.79 0.09 $0
03/03/2022 Q4 2021 -$0.84 -$0.95 -0.11 $0
11/04/2021 Q3 2021 -$0.80 -$0.87 -0.07 $0
08/05/2021 Q2 2021 -$0.73 -$0.90 -0.17 $0
05/05/2021 Q1 2021 -$0.66 -$0.76 -0.1 $0
03/03/2021 Q4 2020 -$0.69 -$0.85 -0.16 $0
11/10/2020 Q3 2020 -$0.73 -$0.63 0.1 $0
08/13/2020 Q2 2020 -$0.60 -$0.60 0 $0
05/11/2020 Q1 2020 -$0.46 -$1.00 -0.54 $0
12/30/2019 Q4 2019 -$0.55 $0
 

Passage Bio, Inc. Earnings: FAQ's

When is Passage Bio, Inc.'s earnings date?

Passage Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 3rd, 2025 based off last year's report dates.

Did Passage Bio, Inc. beat their earnings estimates last quarter?

In the previous quarter, Passage Bio, Inc. (:PASG) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.31 by $0.05.

How can I listen to Passage Bio, Inc.'s earnings conference call?

The conference call for Passage Bio, Inc.'s latest earnings report can be listened to online.

How can I read Passage Bio, Inc.'s conference call transcript?

The conference call transcript for Passage Bio, Inc.'s latest earnings report can be read online.

How much profit does Passage Bio, Inc. generate each year?

Passage Bio, Inc. (:PASG) has a recorded net income of $0. Passage Bio, Inc. has generated $-1.86 earnings per share over the last four quarters.

What is Passage Bio, Inc.'s price-to-earnings ratio?

Passage Bio, Inc. (:PASG) has a price-to-earnings ratio of -0.58 and price/earnings-to-growth ratio is -0.04.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED